Heparin-like effect resistant to protamine in a child with haemorrhagic shock. Do we need heparinase?

M. Nacoti,D. Cantù,D. Bonacina,F. Lussana,E. Bonanomi,M. Marchetti,A. Falanga

DOI: https://doi.org/10.2450/2017.0088-17

2018-07-01

Abstract:Introduction In patients with chronic and acute liver disease and sepsis, the liver is exposed to a neutrophil-mediated injury and inflammation, which may lead to the release of endogenous heparinoids (e.g. heparan sulphate and dermatan sulphate) from the vascular endothelium into the blood stream1. These substances can cause a heparin-like effect (HLE) by inhibiting activated clotting factor Xa in blood and may, therefore, contribute to the coagulopathy and increased risk of bleeding in these patients2-5. In this regard, it is well known that the liver contains abundant parenchymal deposits of endogenous heparinoids, heparan sulphate being the predominant2,3. Additionally, in patients with acute liver failure, the ability to eliminate circulating HLE substances is likely to be greatly impaired due to the important reduction of liver function. Furthermore, during sepsis, mast cells can release HLE substances6. The only drug approved in the USA and European Union to reverse heparin activity is protamine sulphate. This drug has a good binding affinity for high molecular weight molecules, such as unfractionated heparin, but is unable to antagonise low molecular weight heparins7. HLE substances typically have a molecular weight similar to that of low molecular weight heparins, thus are not neutralised by protamine. In contrast, heparinase I, an enzyme isolated from Flavobacterium heparinum, is able to neutralise not only unfractionated heparin, but also low molecular weight heparins and several HLE substances7-9. Thromboelastography (TEG) is a global haemostatic assay which, upon addition of a variety of activators and inhibitors, is capable of evaluating various parameters of haemostasis simultaneously in whole blood. When conducted in the presence of heparinase I, it can reveal the presence of heparin and HLE7.